1
/
of
1
Elabscience
SKU:E-CL-H1454
Human C1q(Complement 1q) CLIA Kit
Human C1q(Complement 1q) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the HUMAN C1q (Complement 1q) CLIA Kit, a cutting-edge diagnostic tool designed to accurately measure the levels of C1q in human samples. This high-quality kit is meticulously crafted to provide precise and reliable results, making it an indispensable asset in clinical laboratories and research facilities.
The HUMAN C1q CLIA Kit utilizes the Chemiluminescent Immunoassay (CLIA) technique, a highly sensitive and specific method that ensures optimal detection and quantification of C1q. With its advanced technology, this kit offers exceptional sensitivity, enabling the detection of even low levels of C1q with utmost accuracy.
This comprehensive kit includes all the necessary components for seamless and efficient testing. It comprises microplates pre-coated with monoclonal antibodies specific to C1q, along with a set of standards, controls, and reagents. The user-friendly protocol allows for straightforward and hassle-free execution, ensuring consistent and reproducible results.
The HUMAN C1q CLIA Kit is designed to cater to the diverse needs of researchers and clinicians alike. Its wide dynamic range enables the quantification of C1q levels across a broad spectrum, facilitating comprehensive analysis and interpretation of results. Moreover, this kit exhibits excellent precision and minimal inter-assay variability, guaranteeing reliable and consistent outcomes.
With its exceptional performance and accuracy, the HUMAN C1q CLIA Kit is an invaluable tool for various applications. It enables the assessment of C1q levels in autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and vasculitis. Additionally, it aids in the diagnosis and monitoring of complement deficiencies and complement-mediated disorders.
Invest in the HUMAN C1q CLIA Kit and unlock a world of possibilities in the field of complement research. With its unparalleled sensitivity, reliability, and ease of use, this kit empowers researchers and clinicians to delve deeper into the intricate mechanisms of the complement system, ultimately leading to enhanced diagnostic capabilities and improved patient care.
The HUMAN C1q CLIA Kit utilizes the Chemiluminescent Immunoassay (CLIA) technique, a highly sensitive and specific method that ensures optimal detection and quantification of C1q. With its advanced technology, this kit offers exceptional sensitivity, enabling the detection of even low levels of C1q with utmost accuracy.
This comprehensive kit includes all the necessary components for seamless and efficient testing. It comprises microplates pre-coated with monoclonal antibodies specific to C1q, along with a set of standards, controls, and reagents. The user-friendly protocol allows for straightforward and hassle-free execution, ensuring consistent and reproducible results.
The HUMAN C1q CLIA Kit is designed to cater to the diverse needs of researchers and clinicians alike. Its wide dynamic range enables the quantification of C1q levels across a broad spectrum, facilitating comprehensive analysis and interpretation of results. Moreover, this kit exhibits excellent precision and minimal inter-assay variability, guaranteeing reliable and consistent outcomes.
With its exceptional performance and accuracy, the HUMAN C1q CLIA Kit is an invaluable tool for various applications. It enables the assessment of C1q levels in autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and vasculitis. Additionally, it aids in the diagnosis and monitoring of complement deficiencies and complement-mediated disorders.
Invest in the HUMAN C1q CLIA Kit and unlock a world of possibilities in the field of complement research. With its unparalleled sensitivity, reliability, and ease of use, this kit empowers researchers and clinicians to delve deeper into the intricate mechanisms of the complement system, ultimately leading to enhanced diagnostic capabilities and improved patient care.
Share
